These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
461 related items for PubMed ID: 12286473
1. RU 486: an overview of mifepristone and its potential applications. Contracept Rep; 1993 May; 4(2):7-9. PubMed ID: 12286473 [Abstract] [Full Text] [Related]
2. Antiprogestogens: from abortion to contraception. Prog Hum Reprod Res; 1992 May; (22):6-7. PubMed ID: 12286013 [Abstract] [Full Text] [Related]
3. Life after Roe v. Wade. Bauerlein M. Utne Read; 1992 May; ():17-20. PubMed ID: 12343822 [Abstract] [Full Text] [Related]
5. RU 486 research forges on, despite political hurdles. Watanabe ME. Scientist; 1994 Jan 24; 8(2):14-5. PubMed ID: 12288152 [Abstract] [Full Text] [Related]
6. Post-coital contraception. Haspels AA. IPPF Med Bull; 1988 Oct 24; 22(5):1-3. PubMed ID: 12281624 [Abstract] [Full Text] [Related]
7. Uses of RU 486: a clinical update. Elia D. IPPF Med Bull; 1986 Oct 24; 20(5):1-2. PubMed ID: 12341333 [Abstract] [Full Text] [Related]
8. [Population Council responsible for RU486 clinical trials in USA]. Aguillaume CJ. Ref Gynecol Obstet; 1993 Apr 24; 1(4):392. PubMed ID: 12288154 [Abstract] [Full Text] [Related]
9. Abortion. Is RU 486/PG in its current form likely to be appropriate for women in Bangladesh? Kabir S, Germain A. Newsl Womens Glob Netw Reprod Rights; 1992 Apr 24; (38):39-45. PubMed ID: 12285435 [Abstract] [Full Text] [Related]
10. [The role of the progesterone antagonist, RU 486 (mifepristone), in preoperative cervical dilatation during the luteal phase. A randomized double-blind study]. Fernandez H, Durlot F, Dubois C, Ulmann A, Frydman R. Contracept Fertil Sex (Paris); 1990 Jan 24; 18(1):41-3. PubMed ID: 12283016 [Abstract] [Full Text] [Related]
11. The clinical use of RU 486 (Mefipristone). Herrmann W. Res Reprod; 1989 Oct 24; 21(4):3. PubMed ID: 12282921 [Abstract] [Full Text] [Related]
13. Mifepristone: a potential contraceptive. Heikinheimo O, Archer DF. Clin Obstet Gynecol; 1996 Jun 24; 39(2):461-8. PubMed ID: 8734010 [Abstract] [Full Text] [Related]
14. Mifepristone (RU 486) in the United States. What does the future hold? Rosenfield A. N Engl J Med; 1993 May 27; 328(21):1560-1. PubMed ID: 8479494 [Abstract] [Full Text] [Related]
15. Contraceptive technologies: how much choice do we really have? Fishel J. ZPG Report; 1997 May 27; 29(2):4-6. PubMed ID: 12293118 [Abstract] [Full Text] [Related]
18. RU-486 and the politics of reproduction. Rosenfield A. Female Patient; 1989 Mar 27; 14(3):69, 73-4. PubMed ID: 12342816 [Abstract] [Full Text] [Related]
19. Contraception after unprotected sex. Blaney CL. Netw Res Triangle Park N C; 1994 Dec 27; 15(2):4-8. PubMed ID: 12319047 [Abstract] [Full Text] [Related]
20. Mifepristone (RU 486) compared with high-dose estrogen and progestogen for emergency postcoital contraception. Glasier A, Thong KJ, Dewar M, Mackie M, Baird DT. N Engl J Med; 1992 Oct 08; 327(15):1041-4. PubMed ID: 1522839 [Abstract] [Full Text] [Related] Page: [Next] [New Search]